A handout photograph distributed by Syria's national news agency SANA on May 22,2013, show detained men, blindfolded and handcuffed, described by SANA as "terrorists fighters", a term commonly used to describe rebels fighting to topple President Bashar al-Assad, in Qusair, near Homs.    SANA/Handout via Reuters

Reuters Photojournalism

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.  See more 

Photo

Devastated by Tornado

A huge tornado tears through an Oklahoma City suburb.  Slideshow 

Photo

The drone wars

The frontlines of America's covert drone program.  Slideshow 

Sponsored Links

Germany's Bayer considers diabetes device unit sale: report

Related Topics

The logo of Germany's largest drugmaker Bayer HealthCare Pharmaceuticals is pictured on the front of its building in Berlin April 28, 2011. REUTERS/Fabrizio Bensch

The logo of Germany's largest drugmaker Bayer HealthCare Pharmaceuticals is pictured on the front of its building in Berlin April 28, 2011.

Credit: Reuters/Fabrizio Bensch

FRANKFURT | Wed May 9, 2012 1:14am EDT

FRANKFURT (Reuters) - Germany's largest drugmaker Bayer is considering the sale of its blood glucose meters business, a German newspaper reported.

Bayer has held talks with prospective buyers of its Diabetes Care unit, which has annual sales of about 1 billion euros ($1.3 billion), Financial Times Deutschland said in its Wednesday edition, citing sources close to the possible suitors and in the financial industry.

The paper said that Bayer declined to comment.

($1 = 0.7695 euros)

(Reporting by Ludwig Burger; Editing by Ed Lane)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.